The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies
Introduction: The handling of drug-drug interactions regarding QTc-prolongation (QT-DDIs) is not well defined. A clinical decision support (CDS) tool will support risk management of QT-DDIs. Therefore, we studied the effect of a CDS tool on the proportion of QT-DDIs for which an intervention was con...
Saved in:
Main Authors: | Florine A. Berger (Author), Heleen van der Sijs (Author), Teun van Gelder (Author), Patricia M. L. A. van den Bemt (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients
by: Florine A. Berger, et al.
Published: (2021) -
The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
by: Justine M. Z. van Tongeren, et al.
Published: (2020) -
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
by: Qasim Khan, et al.
Published: (2017) -
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
by: Holger Michel, et al.
Published: (2023) -
Drugs that enlarge the QT interval of the electrocardiogram.
by: Pedro Miguel Milián Vázquez, et al.
Published: (2006)